Intervensi Electroconvulsive Therapy (ECT) pada Skizofrenia Katatonik

Rahaju Budhi Muljanto, Adriesti Herdaetha, Wijaya Kusuma, Ahmad Ahmad

Abstract


Laporan kasus ini mendokumentasikan intervensi Electroconvulsive Therapy (ECT) pada seorang pria berusia 30 tahun yang didiagnosis dengan skizofrenia katatonik, di mana pengobatan farmakologis tidak memberikan hasil yang memadai. Skizofrenia katatonik merupakan subtipe yang jarang namun parah, ditandai dengan gangguan motorik seperti katalepsi, mutisme, dan gerakan motorik yang tidak teratur. Pasien dalam laporan ini menunjukkan resistensi terhadap obat-obatan antipsikotik, termasuk Haloperidol dan Clozapine, yang mendorong tim medis untuk melakukan ECT sebagai alternatif terapeutik. Prosedur ECT dilakukan dengan pengawasan ketat, dan hasilnya menunjukkan perbaikan signifikan pada gejala katatonik pasien, dengan pengurangan halusinasi dan peningkatan interaksi sosial. Laporan ini menegaskan efektivitas ECT dalam mengatasi gejala katatonik pada kasus skizofrenia yang resisten terhadap pengobatan, serta pentingnya pendekatan individualisasi dalam pengelolaan gangguan ini.

Keywords


Electroconvulsive Therapy (ECT); Skizofrenia Katatonik; Resistensi Pengobatan; Antipsikotik

Full Text:

PDF

References


Ali, S. A., Mathur, N., Malhotra, A. K., & Braga, R. J. (2019). Electroconvulsive therapy and schizophrenia: A systematic review. *Molecular Neuropsychiatry, 5*(2), 75-83. https://doi.org/10.1159/000497376

Arumugham, S. S., Thirthalli, J., & Andrade, C. (2016). Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. *Expert Review of Clinical Pharmacology, 9*(9), 1245-1252. https://doi.org/10.1080/17512433.2016.1200971

Grover, S., Hazari, N., & Kate, N. (2015). Combined use of clozapine and ECT: A review. *Acta Neuropsychiatrica, 27*(3), 131-142. https://doi.org/10.1017/neu.2015.8

Hany, M., Rehman, B., Rizvi, A., et al. (2024). Schizophrenia. In *StatPearls* [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK539864/

Jain, A., & Mitra, P. (2024). Catatonic schizophrenia. In *StatPearls* [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK563222/

Lally, J., Tully, J., Robertson, D., Stubbs, B., Gaughran, F., & MacCabe, J. H. (2016). Augmentation of clozapine with electroconvulsive therapy in treatment-resistant schizophrenia: A systematic review and meta-analysis. *Schizophrenia Research, 171*(1-3), 215-224. https://doi.org/10.1016/j.schres.2016.01.024

Lloyd, J. R., Silverman, E. R., Kugler, J. L., & Cooper, J. J. (2020). Electroconvulsive therapy for patients with catatonia: Current perspectives. *Neuropsychiatric Disease and Treatment, 16*, 2191-2208. https://doi.org/10.2147/NDT.S231573

Luchini, F., Medda, P., Mariani, M. G., Mauri, M., Toni, C., & Perugi, G. (2015). Electroconvulsive therapy in catatonic patients: Efficacy and predictors of response. *World Journal of Psychiatry, 5*(2), 182-192. https://doi.org/10.5498/wjp.v5.i2.182

Mahmood, S., Tan, X., Chen, B., & Tor, P. C. (2024). The influence of age on ECT efficacy in depression, mania, psychotic depression, and schizophrenia: A transdiagnostic analysis. *Journal of Psychiatric Research, 177*, 203-210. https://doi.org/10.1016/j.jpsychires.2024.07.012

Nucifora, F. C., Woznica, E., Lee, B. J., Cascella, N., & Sawa, A. (2019). Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. *Neurobiology of Disease, 131*, 104257. https://doi.org/10.1016/j.nbd.2018.08.016

Pawełczyk, T., Kołodziej-Kowalska, E., Pawełczyk, A., & Rabe-Jabłońska, J. (2014). Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms. *Psychiatry Research, 220*(1-2), 175-180. https://doi.org/10.1016/j.psychres.2014.07.071

Pirnia, T., Joshi, S. H., Leaver, A. M., Vasavada, M., Njau, S., Woods, R. P., Espinoza, R., & Narr, K. L. (2016). Electroconvulsive therapy and structural neuroplasticity in neocortical, limbic, and paralimbic cortex. *Translational Psychiatry, 6*(6), e832. https://doi.org/10.1038/tp.2016.102

Remington, G., Addington, D., Honer, W., Ismail, Z., Raedler, T., & Teehan, M. (2017). Guidelines for the pharmacotherapy of schizophrenia in adults. *The Canadian Journal of Psychiatry, 62*(9), 604-616. https://doi.org/10.1177/0706743717720448

Salik, I., & Marwaha, R. (2024). Electroconvulsive therapy. In *StatPearls* [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538266/

Sanghani, S. N., Petrides, G., & Kellner, C. H. (2018). Electroconvulsive therapy (ECT) in schizophrenia: A review of recent literature. *Current Opinion in Psychiatry, 31*(3), 213-222. https://doi.org/10.1097/YCO.0000000000000418

Sinclair, D. J., Zhao, S., Qi, F., Nyakyoma, K., Kwong, J. S., & Adams, C. E. (2019). Electroconvulsive therapy for treatment-resistant schizophrenia. *Cochrane Database of Systematic Reviews, 2019*(3), CD011847. https://doi.org/10.1002/14651858.CD011847.pub2

Sharma, P., & Sharma, P. (2024). Biomarkers of electroconvulsive therapy (ECT) response in treatment-resistant schizophrenia (TRS). *Kathmandu University Medical Journal, 85*(1), 107-111.




DOI: https://doi.org/10.32807/bnj.v6i1.1717

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Bima Nursing Journal